BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Lymphocyte
,
Early pregnancy factor
,
Prozac
,
rs6983267
,
FGF21
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tissues, Lymphatic
(tissue)
Summary
General Info
Body Atlas
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Transcription factor TCF-1 regulates the functions, but not the development, of lymphoid tissue indu…
Tubulointerstitial B-cell infiltration and tertiary lymphoid tissue in adult-onset immunoglobulin A …
Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLB…
Depletion of T and B cells in lymphoid tissues of mice induced by oclacitinib, a Janus kinase inhibi…
Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex v…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients
Velcade in MALT Lymphoma Patients
Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type
Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) L…
Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ